Overview

Screening Non Small Cell Lung Cancer With Bone Metastasis and Efficacy and Safety Research of Receiving Bisphosphonates

Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
A multicenter Prospective Study to assess the screening methods, parameter of NTX and the efficacy and safety of zoledronic acid treatment in addition to anti-tumor therapy in patients of non-small cell cancer with bone metastasis in china.
Phase:
Phase 4
Details
Lead Sponsor:
Sun Yat-sen University
Collaborator:
Novartis
Treatments:
Diphosphonates